Esperion Therapeutics (ESPR) Return on Capital Employed Growth (1y) (2014 - 2026)
Esperion Therapeutics (ESPR) Return on Capital Employed Growth (1y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.86 Bn | 88.00 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.98 Bn | 32.24 Bn | 1.97 Bn | 696.00 |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | -507.00 |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn | -723.00 |
| 5 | United Therapeutics | 23.01 Bn | 20.86 Bn | 648.10 Mn | 89.00 |
| 6 | RedHill Biopharma | 22.02 Bn | 22.02 Bn | - | - |
| 7 | Viatris | 20.40 Bn | 18.59 Bn | 1.16 Bn | 944.00 |
| 8 | Neurocrine Biosciences | 17.77 Bn | 16.46 Bn | 800.70 Mn | 448.00 |
| 9 | Elanco Animal Health | 12.74 Bn | 12.31 Bn | 785.00 Mn | 1,195.00 |
| 10 | Esperion Therapeutics | 799.30 Mn | 643.14 Mn | 45.53 Mn | 10,973.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10,973.00 |
| Dec 31, 2025 | -1,295.00 |
| Sep 30, 2025 | 83,430.00 |
| Jun 30, 2025 | -9,907.00 |
| Mar 31, 2025 | -3,570.00 |
| Dec 31, 2024 | 33,712.00 |
| Sep 30, 2024 | 18,235.00 |
| Jun 30, 2024 | 12,745.00 |
| Mar 31, 2024 | 9,213.00 |
| Dec 31, 2023 | -17,592.00 |
| Sep 30, 2023 | -8,731.00 |
| Jun 30, 2023 | -3,907.00 |
| Mar 31, 2023 | -5,389.00 |
| Dec 31, 2022 | 311.00 |
| Sep 30, 2022 | 6,772.00 |
| Jun 30, 2022 | 6,231.00 |
| Mar 31, 2022 | -649.00 |
| Dec 31, 2021 | -4,020.00 |
| Sep 30, 2021 | -11,344.00 |
| Jun 30, 2021 | -10,713.00 |